ASGR1 and metabolic dysfunction-associated steatohepatitis: The expressions of all three miRNA biomarkers were significantly greater in ASGR1+ EVs from NASH subjects compared with controls (p = 0.012 (miR-122), p = 0.013 (miR-192), and p = 0.032 (miR-128-3p)).